Login / Signup

The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta-analysis.

Ting YangXin TianChao-Yang ChenLing-Yun MaShuang ZhouMin LiYe WuYing ZhouYi Min Cui
Published in: British journal of clinical pharmacology (2020)
Fingolimod may offer benefits for RMS patients and presents an acceptable safety profile.
Keyphrases
  • multiple sclerosis
  • end stage renal disease
  • white matter
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • rheumatoid arthritis